Year To Quarter End Consolidated Statement Of Income

Modalis Therapeutics Corporation - Filing #7337841

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Year to quarter end consolidated statement of income
Statement of income
Selling, general and administrative expenses
Selling, general and administrative expenses
67,482,000 JPY
71,137,000 JPY
Operating profit (loss)
-490,087,000 JPY
-514,446,000 JPY
Non-operating income
Interest income
7,000 JPY
14,000 JPY
Non-operating income
34,632,000 JPY
7,271,000 JPY
Non-operating expenses
Interest expenses
1,032,000 JPY
1,108,000 JPY
Non-operating expenses
1,990,000 JPY
2,731,000 JPY
Ordinary profit (loss)
-457,445,000 JPY
-509,905,000 JPY
Extraordinary losses
Impairment losses
188,000 JPY
22,161,000 JPY
Extraordinary losses
188,000 JPY
22,161,000 JPY
Profit (loss) before income taxes
-457,633,000 JPY
-532,067,000 JPY
Income taxes - current
303,000 JPY
304,000 JPY
Income taxes
303,000 JPY
304,000 JPY
Profit (loss)
-457,936,000 JPY
-532,371,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
-457,936,000 JPY
-532,371,000 JPY
Other comprehensive income
Foreign currency translation adjustment
-428,000 JPY
1,250,000 JPY
Other comprehensive income
-428,000 JPY
1,250,000 JPY
Comprehensive income
-458,364,000 JPY
-531,121,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-458,364,000 JPY
-531,121,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.